Postmenopausal Hormone Therapy for Chronic Conditions

Hormone therapy, specifically estrogen and progesterone, helps postmenopausal women prevent chronic illnesses.

FREMONT, CA : The use of hormone treatment for the primary prevention of cardiovascular disease (CVD) in postmenopausal women has been the subject of significant research. Hormone therapy might have a potential preventive benefit against heart disease. Specific cardiovascular events are associated with hormone therapy. Hormone therapy is not advised for the primary prevention of cardiovascular diseases. In a manner analogous to cardiovascular disease, hormone therapy is connected to an elevated risk of stroke. Hormone replacement therapy is not generally suggested for this objective because it is associated with several potential adverse effects. 

Postmenopausal women receiving hormone therapy had an increased chance of stroke. Hormone replacement treatment is not suggested as a significant method of stroke prevention. Hormone therapy, and particularly estrogen therapy, is beneficial in decreasing bone loss and reducing the incidence of osteoporotic fractures in postmenopausal women who have the condition. Hormone therapy is usually reserved for women with a considerable osteoporosis risk or those who cannot tolerate other medications to prevent osteoporosis. This is because there are possible dangers associated with long-term usage of hormone therapy.